Skip to content

The Effect of Combined 650 nm and Infrared Laser on Chronic Diabetic Foot Ulcer Surface Area:

The Effect of Combined 650 nm and Infrared Laser on Chronic Diabetic Foot Ulcer Surface Area: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05517863
Acronym
wounds
Enrollment
45
Registered
2022-08-26
Start date
2022-03-01
Completion date
2022-07-27
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot, Wound Heal

Keywords

650 nm laser, infrared laser, chronic diabetic foot ulcer, wound surface area

Brief summary

Objective: investigate the effect of combined 650 nm and infrared laser on chronic diabetic foot ulcer surface area. Participants: The forty five patients will assigned randomly into three equal groups, each group consist of 15 patients, group A received laser therapy in sequential mode, group B received laser therapy in separate mode and the control group C receive traditional wound care

Detailed description

Objective: investigate the effect of combined 650 nm and infrared laser on chronic diabetic foot ulcer surface area. Participants: The forty five patients will assigned randomly into three equal groups, each group consist of 15 patients, group A received laser therapy in sequential mode, group B received laser therapy in separate mode and the control group C receive traditional wound care Outcomes: the primary outcomes were the wound surface area measurement, % of wound complete closure and % of days needed for surface area reduction before and after receiving the treatment protocol for two consequetive months, and the secondary outcomes were % of wound cause and location frequencies

Interventions

DEVICElaser therapy

All patients received 2 sessions of laser therapy / week in two consecutive months of treatment aiming complete wound closure , patients received & infrared laser therapy plus traditional wound care: (I) Use red & infrared laser therapy device with 4 different wavelengths in a synchronized mode: 1. 980 nm for wound decontamination, improve circulation, lymphatic drainage 2. 915 nm enhances O2 delivery 3. 810 nm increases ATP production 4. 650 nm accelerate surface healing, tissue regeneration plus traditional wound treatment mentioned before

Sponsors

Heidy F. Ahmed
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

the patient didn't know the types of modes of laser applied even in the control group i used light not laser to equalize the blindness

Intervention model description

group A received laser therapy in sequential mode, group B received laser therapy in separate mode and the control group C receive traditional wound care

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* 1- Diabetic patients with either type I or II 2- Age from 18-60 years old, both sexes 3- Ulcer lasting longer than two months 4- DFU grade 1 or 2 according to Wagner classification. 5- All patients able to walk dependently

Exclusion criteria

1. Patients with vascular disease 2. Patients with fixed ankle deformity as Charcot foot or stiffness 3. Patients with any type of osteomyelitis associated with DFU 4. Patients with renal or hepatic failure 5. BMI \< 30 kg/m2 as Obesity can cause poor perfusion due to vascular insufficiencies; altered population of immune mediators may lengthen the inflammatory process & decrease oxygenation of subcutaneous adipose tissue which is liable to be infected.

Design outcomes

Primary

MeasureTime frameDescription
percent of wound size measurement methodstwo consecutive monthsweekly by 1. a ruler (wound area was calculated by measuring and multiplying the greatest length by the greatest width perpendicular to the greatest length) 2. a sterile transparent film sheet
percent of wounds complete closuretwo consecutive monthsmeasure percent of wounds complete closure in each group

Secondary

MeasureTime frameDescription
percent of each type of wound causetwo consecutive monthsdifferent wound cause diabetic foot ulcers and healing time
percent of each wound locationtwo consecutive monthsdifferent wound location in diabetic foot ulcers and healing time
percent of days needed for surface area reductiontwo consecutive monthsmeasure the days needed to decrease surface area in each group

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026